Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Association between the ROBO1 gene and body mass index in patients using antipsychotics.

Vehof J, Al Hadithy AF, Burger H, Snieder H, Risselada AJ, Wilffert B, Cohen D, Arends J, Wiersma D, Mulder H, Bruggeman R.

Psychiatr Genet. 2011 Aug;21(4):202-7. doi: 10.1097/YPG.0b013e3283458a51.

PMID:
21412182
2.

Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication.

Vehof J, Risselada AJ, Al Hadithy AF, Burger H, Snieder H, Wilffert B, Arends J, Wunderink L, Knegtering H, Wiersma D, Cohen D, Mulder H, Bruggeman R.

Psychopharmacology (Berl). 2011 Jul;216(2):257-65. doi: 10.1007/s00213-011-2211-x. Epub 2011 Feb 19.

3.
4.

The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study.

Mulder H, Franke B, van der-Beek van der AA, Arends J, Wilmink FW, Egberts AC, Scheffer H.

Pharmacogenomics J. 2007 Oct;7(5):318-24. Epub 2006 Oct 3.

PMID:
17016522
5.

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals.

Theisen FM, Hinney A, Brömel T, Heinzel-Gutenbrunner M, Martin M, Krieg JC, Remschmidt H, Hebebrand J.

Psychiatr Genet. 2004 Sep;14(3):139-42.

PMID:
15318026
6.

DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.

Popp J, Leucht S, Heres S, Steimer W.

Pharmacogenomics J. 2009 Feb;9(1):71-7. doi: 10.1038/tpj.2008.5. Epub 2008 Mar 11.

PMID:
18332898
7.

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism.

Miller DD, Ellingrod VL, Holman TL, Buckley PF, Arndt S.

Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):97-100.

PMID:
15635667
8.

Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.

Gregoor JG, van der Weide J, Mulder H, Cohen D, van Megen HJ, Egberts AC, Heerdink ER.

J Clin Psychopharmacol. 2009 Feb;29(1):21-5. doi: 10.1097/JCP.0b013e31819359be.

PMID:
19142102
9.

No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.

Zhang ZJ, Yao ZJ, Zhang XB, Chen JF, Sun J, Yao H, Hou G, Zhang XB.

Acta Pharmacol Sin. 2003 Mar;24(3):235-40.

10.

ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics.

Liu YR, Loh EW, Lan TH, Chen SF, Yu YH, Chang YH, Huang CJ, Hu TM, Lin KM, Yao YT, Chiu HJ.

Pharmacogenomics J. 2010 Feb;10(1):30-9. doi: 10.1038/tpj.2009.55. Epub 2009 Nov 17. Erratum in: Pharmacogenomics J. 2012 Apr;12(2):184.

PMID:
19918262
11.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
12.

Association of RAGE gene polymorphisms with coronary artery disease in the Korean population.

Yoon SJ, Park S, Shim CY, Park CM, Ko YG, Choi D, Park HY, Oh B, Kim H, Jang Y, Chung N.

Coron Artery Dis. 2007 Feb;18(1):1-8.

PMID:
17172923
13.

No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.

Lee HY, Kim DJ, Lee HJ, Choi JE, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):276-80. doi: 10.1016/j.pnpbp.2008.11.013. Epub 2008 Dec 3.

PMID:
19059448
14.

Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.

Gregoor JG, Mulder H, Cohen D, van Megen HJ, Egberts TC, Heerdink ER, van der Weide J.

J Clin Psychopharmacol. 2010 Dec;30(6):702-5.

PMID:
21105285
15.

The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients.

Di Blasio AM, van Rossum EF, Maestrini S, Berselli ME, Tagliaferri M, Podestà F, Koper JW, Liuzzi A, Lamberts SW.

Clin Endocrinol (Oxf). 2003 Jul;59(1):68-74.

PMID:
12807506
16.

Genetic analyses of roundabout (ROBO) axon guidance receptors in autism.

Anitha A, Nakamura K, Yamada K, Suda S, Thanseem I, Tsujii M, Iwayama Y, Hattori E, Toyota T, Miyachi T, Iwata Y, Suzuki K, Matsuzaki H, Kawai M, Sekine Y, Tsuchiya K, Sugihara G, Ouchi Y, Sugiyama T, Koizumi K, Higashida H, Takei N, Yoshikawa T, Mori N.

Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1019-27. doi: 10.1002/ajmg.b.30697.

PMID:
18270976
17.

Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population.

Gazzerro P, Caruso MG, Notarnicola M, Misciagna G, Guerra V, Laezza C, Bifulco M.

Int J Obes (Lond). 2007 Jun;31(6):908-12. Epub 2006 Dec 12.

PMID:
17160086
18.

[Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].

Zhang Z, Zhang X, Yao Z, Chen J, Sun J, Yao H, Hou G, Zhang X, Reynolds GP.

Zhonghua Yi Xue Za Zhi. 2002 Aug 25;82(16):1097-101. Chinese.

PMID:
12425817
19.

LEPR p.Q223R Polymorphism influences plasma leptin levels and body mass index in Tunisian obese patients.

Ben Ali S, Kallel A, Sediri Y, Ftouhi B, Feki M, Slimene H, Jemaa R, Kaabachi N.

Arch Med Res. 2009 Apr;40(3):186-90. doi: 10.1016/j.arcmed.2009.02.008. Epub 2009 Apr 5.

PMID:
19427969
20.

Supplemental Content

Support Center